Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hypoalphalipoproteinemias × Rosuvastatin Calcium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Venous Thromboembolism 1 Stroke 1 Pulmonary Embolism 1 Prostatic Neoplasms 1 Neoplasms 1 Ischemic Attack, Transient 1 Hypoalphalipoproteinemias 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Breast Neoplasms 1 Atherosclerosis 1

Interventions

Rosuvastatin Calcium 1 Castration 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04776889 2021-03-02

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

National Cancer Institute, Egypt

Phase 4 Completed

Prostatic Neoplasms, Hypoalphalipoproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡